{
    "nctId": "NCT01815476",
    "briefTitle": "The Prone Breast Radiation Therapy Trial",
    "officialTitle": "A Multicentre Randomized Controlled Clinical Trial for the Reduction of Acute Skin Reaction in Adjuvant Breast Radiation in Large Breasted Women Using a Prone Technique - The Prone Breast Trial",
    "overallStatus": "COMPLETED",
    "conditions": "Ductal Carcinoma In Situ, Invasive Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 378,
    "primaryOutcomeMeasure": "Moist Desquamation",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* confirmed histological diagnosis of breast carcinoma or ductal carcinoma in situ (DCIS);\n* treated with BCT;\n* no indication for treatment of regional LN;\n* Women with a bra size of 40 inches or greater, or a pre-surgery cup size of D or greater\n\nExclusion Criteria:\n\n* Regional Lymph Node XRT indicated;\n* Bilateral breast cancer;\n* unhealed wound (skin not closed and/or infection);\n* previous XRT to the same breast;\n* unable to lie prone;\n* presence of active connective tissue disease;\n* pregnancy;\n* unacceptable heart exposure (as measured by \\> 10% of the heart receiving 50% of the prescribed dose, i.e. V25Gy \\> 10%);\n* adequate coverage of postoperative tumour bed not technically possible",
    "sex": "FEMALE",
    "minimumAge": "N/A",
    "stdAges": "CHILD, ADULT, OLDER_ADULT"
}